Cargando…
Harnessing NK Cells to Control Metastasis
In recent years, tumor immunotherapy has produced remarkable results in tumor treatment. Nevertheless, its effects are severely limited in patients with low or absent pre-existing T cell immunity. Accordingly, metastasis remains the major cause of tumor-associated death. On the other hand, natural k...
Autores principales: | Deng, Xuewen, Terunuma, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781233/ https://www.ncbi.nlm.nih.gov/pubmed/36560427 http://dx.doi.org/10.3390/vaccines10122018 |
Ejemplares similares
-
Exploring the Utility of NK Cells in COVID-19
por: Deng, Xuewen, et al.
Publicado: (2022) -
Immunosurveillance of Cancer and Viral Infections with Regard to Alterations of Human NK Cells Originating from Lifestyle and Aging
por: Deng, Xuewen, et al.
Publicado: (2021) -
Harnessing NK Cell Checkpoint-Modulating Immunotherapies
por: Chauhan, Sachin Kumar Singh, et al.
Publicado: (2020) -
Harnessing NK Cells for Cancer Treatment
por: Minetto, Paola, et al.
Publicado: (2019) -
Harnessing the Potential of NK Cell-Based Immunotherapies against Multiple Myeloma
por: Reina-Ortiz, Chantal, et al.
Publicado: (2022)